| Bioactivity | Thymocartin TFA is the TFA salt form of Thymocartin (HY-105025). Thymocartin TFA inhibits apoptosis of peripheral blood lymphocytes in HIV infected individuals. Thymocartin TFA is potential for immunodeficiency diseases research[1][2]. | ||||||
| Formula | C21H40N8O7.xC2HF3O2 | ||||||
| Molar Mass | 516.59 (free acid) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. la Szende B, et al., Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin[J]. Medical Science Monitor, 1997, 3(4): BR456-BR459. [2]. S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6. |
Thymocartin TFA
CAS: F: C21H40N8O7.xC2HF3O2 W: 516.59 (free acid)
Thymocartin TFA is the TFA salt form of Thymocartin (HY-105025). Thymocartin TFA inhibits apoptosis of peripheral blood
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.